With advanced oncology infrastructure, Hospital Ruber International offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1982, the ISO accredited hospital is located in Madrid, Spain, and has 345 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.